Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Fatigue 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Therapeutics 15Exercise 10Yoga 9Psychiatric Rehabilitation 8Mental Status and Dementia Tests 4Early Intervention, Educational 4Acupuncture Therapy 4Walking 3Surveys and Questionnaires 3Educational Status 3Control Groups 3Ultraviolet Therapy 2Transcranial Direct Current Stimulation 2Standard of Care 2Saline Solution 2Resistance Training 2Physical Therapy Modalities 2Music Therapy 2Methods 2Gene Expression Profiling 2Exercise Therapy 2Exercise Movement Techniques 2Enzyme-Linked Immunosorbent Assay 2Drug Therapy 2stinging nettle lectin 1reparixin 1peppermint oil 1methyl hydroxyethyl cellulose 1exemestane 1coenzyme Q10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Infliximab × Breast × Clear all
NCT00112749 2020-07-31

Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer

Jonsson Comprehensive Cancer Center

Phase 2 Terminated
7 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡